Alendronate Sodium Chew Treat
Alendronate Sodium is a compounded formulation containing Alendronate Sodium, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider alendronate sodium for the management of idiopathic hypercalcemia, particularly in feline patients where elevated calcium levels are a clinical priority. It is also a point of discussion in cases of osteolytic bone disease or as part of a management approach for certain bone-related tumors. By modulating the activity of the cells responsible for bone resorption, your veterinarian can manage the internal stability of the skeletal system.
At a pharmacological level, alendronate sodium acts as a potent inhibitor of osteoclast-mediated bone resorption. It binds specifically to the hydroxyapatite crystals within the bone matrix. When osteoclasts—the cells responsible for breaking down bone tissue—begin the resorption process, they internalize the alendronate, which then disrupts their internal biochemical signaling and leads to a decrease in their activity and lifespan. This process may help address the excessive release of calcium into the bloodstream and supports the maintenance of bone mass. Your veterinarian will determine whether alendronate sodium is appropriate based on your pet's kidney health, weight and the specific diagnostic findings.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of alendronate sodium administration include gastrointestinal changes such as a decrease in appetite, vomiting or diarrhea. In humans, bisphosphonates are associated with esophageal irritation and while data in pets continues to evolve, veterinarians often discuss specific administration techniques to ensure the medication reaches the stomach quickly in the context of addressing localized irritation. Owners should watch for signs of physical distress or difficulty swallowing and contact their veterinarian promptly if these behavioral shifts occur.
This medication is typically used with extra caution or avoided in patients with known severe renal impairment, as the kidneys are the primary route of excretion. It is also carefully evaluated in patients with pre-existing low calcium (hypocalcemia) or vitamin D deficiencies. Before starting a protocol, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving, as alendronate can interact with calcium supplements, antacids and certain anti-inflammatory medications. Your veterinarian is the right person to provide guidance on the necessary duration of use and the appropriate monitoring schedule to ensure the management approach remains suitable for your pet's individual health status.
Yes. Alendronate sodium is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While alendronate is available as a commercial tablet, Mixlab can compound this medication into specialized strengths or alternative flavored dosage forms if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss alendronate for cats with idiopathic hypercalcemia because of its ability to inhibit osteoclasts, the cells that release calcium from the bones into the blood. By addressing this activity, the medication may be part of a management approach for systemic calcium levels when other dietary or medical interventions are not sufficient.
Commonly observed responses include digestive upset such as vomiting or a lack of interest in food. You should monitor your pet for any signs of discomfort while eating or swallowing and report any unusual behavior to your veterinarian immediately to ensure the administration protocol is working correctly.
